In the CD133 GBM study, the high levels of CD133 were associated with a GBM subtype with the highest tumor purity (i.e., GBM proneural group), and our findings that the CD133 expression signature levels were significantly correlated with tumor purity (Fig. 3g) may support this assumption. The gene discussed is PROM1; the disease is neoplasm.